Two cases of von Hippel-Lindau syndrome-associated retinal hemangioblastoma treated with belzutifan.

Joseph M Grimes, Alexandera Gershkovich, Dmitry Bogomolny, Brian P Marr

Retinal cases & brief reports（2022）

引用 1|浏览1

暂无评分

摘要

Belzutifan is a promising treatment for RH with the potential for both rapid and sustained tumor regression.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要